Zhongchao Inc

Zhongchao Inc(ZCMD)股票分析

$0.925

-0.043 (-4.68%)收盤時

Loading chart…
High
0.980
Open
0.924
VWAP
0.93
Vol
1.19M
Mkt Cap
3.23M
Low
0.880
Amount
1.10M
EV/EBITDA, TTM
0.00

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.

AI analysis of Zhongchao Inc (ZCMD)

sell

Zhongchao Inc. (ZCMD) is not a good buy right now due to its extremely low current price of $0.92, a staggering year-to-date change of -99.74%, and a negative forward P/E ratio of 0, indicating no expected earnings growth. The recent share consolidation aimed at maintaining Nasdaq compliance has not instilled enough confidence, as evidenced by a 5-day change of -0.43% and a 20-day change of -18.19%. The main risk is the company's significant decline in stock value, which raises concerns about its long-term viability.

估值指標

The current forward P/E ratio for Zhongchao Inc (ZCMD) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

Alphio AI Price Scenarios for ZCMD

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ZCMD

$1.32

情境價格

B

Base

Base · 50%ZCMD

$1.17

情境價格

B

Bear

Bear · 25%ZCMD

$1.00

情境價格

事件時間軸

2026-07-23 (ET)

09:30:00

Zhongchao Enters Agreement to Issue 4.55 Million Shares at $1.10

2026-06-25 (ET)

08:31:00

Zhongchao to Effectuate 1-for-3 Share Consolidation

2026-05-07 (ET)

14:50:00

Zhongchao Plans Best-Efforts Offering of 5.56M Units

2026-02-26 (ET)

08:50:00

Zhongchao to Effectuate 1-for-8 Share Consolidation

資訊

ZCMD FAQ — answered by Alphio AI

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market. It operates in the Academic & Educational Services sector.

Zhongchao Inc. (ZCMD) is not a good buy right now due to its extremely low current price of $0.92, a staggering year-to-date change of -99.74%, and a negative forward P/E ratio of 0, indicating no expected earnings growth. The recent share consolidation aimed at maintaining Nasdaq compliance has not instilled enough confidence, as evidenced by a 5-day change of -0.43% and a 20-day change of -18.19%. The main risk is the company's significant decline in stock value, which raises concerns about its long-term viability.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始